What can I do?
Risks to human health
The grey water footprint of human and veterinary pharmaceuticals
Green medicines – utopia or option?
MEDUWA Declaration 2020 on the Emission of Human & Veterinary Medicines
MEDicines Unwanted in WAter, MEDUWA-Vecht(e)
Enhanced environmental permitting of pharmaceutical plants in the Baltic Sea region. CWPharma project report for GoA4.3
Recommendations for efficient dissemination of environmental information regarding pharmaceuticals Clear Waters from Pharmaceuticals (CWPharma) Activity 4.2 Report
Good practices for take-back and disposal of unused pharmaceuticals in the Baltic Sea region. Clear Waters from Pharmaceuticals (CWPharma) Activity 4.1 Report
Guideline for advanced API removal. CWPharma project report for GoA3.4: Optimisation and control of advanced treatment
Impact of ozonation and post-treatment on ecotoxicological endpoints, water quality, APIs and transformation products. CWPharma project report for GoA3.3: Comparison of post-treatment options
Evaluation and experiences of full-scale ozonation followed by MBBR post-treatment at Kalundborg wastewater treatment plant. CWPharma project report for GoA3.2: Flexible use of existing infrastructure